Biotech Series A Investors & VC Firms
1627 firms in this list, with a median first check of $500K. 369 of them lead rounds. Generated from verified public data and updated continuously.
TriWise Capital
ShenzhenPre-Seed–Series B
1 person
Y Innovations
CambridgeSeed–Series B
1 person
YFY Biotech Management Company
TaipeiSeed–Series B
1 person
SEB Greentech Venture Capital
StockholmSeed–Growth$1.1M – $4.3M
4 people
CEA Investissement
Pre-Seed–Growth
RUSNANO
MoscowSeed–Series A
Cresswell Advisors
TorontoSeed–Series A
1 person
East West Capital Limited
SydneySeed–Late Stage
1 person
ENEA Tech e Biomedical
RomaPre-Seed–Series A
1 person
Panda Capital
Seed–Late Stage
1 person
Shinhan Venture Investment
SeoulSeries A–Series B
1 person
Biomark Capital
GreenwichSeries A–Late Stage$5M – $10M
4 people
SymBiosis
BentonvilleSeed–Late Stage
4 people
BDC Climate Tech Fund II
MontréalSeed–Growth
Ikarian Capital
DallasSeries A–Late Stage
WERU Investment Co. Ltd.
TokyoSeed–Series A
Zhongguancun Development Group
BeijingPre-Seed–Growth
IMM Investment
KangnamPre-Seed–Growth
A. M. Pappas & Associates
DurhamPre-Seed–Series A
1 person
AllosteRx Capital Management (Canada) Inc.
MontrealSeed–Series A
1 person
Bio Sight Capital, Inc.
IbarakiSeed–Series A
1 person
Haibang Capital
HangzhouSeed–Series A
1 person
MENTOR Capital Partners, Ltd.
YardleySeed–Growth
1 person
Nissay Capital
TokyoPre-Seed–Growth
1 person
Related lists
Series A Investors & VC Firms (7336)Series A Investors & VC Firms in North America (4219)Series A Investors & VC Firms in United States (3838)AI & Machine Learning Series A Investors & VC Firms (2604)SaaS Series A Investors & VC Firms (2592)Biotech Investors & VC Firms (2483)Series A Investors & VC Firms in Europe (2383)Fintech Series A Investors & VC Firms (2350)Healthtech Series A Investors & VC Firms (2314)Enterprise Software Series A Investors & VC Firms (2269)
Data sourced from public filings and firms' own websites — see our methodology.







